MedPath

6% HETASTARCH IN 0.9% SODIUM CHLORIDE

6% HETASTARCH IN 0.9% SODIUM CHLORIDE INJECTION 500mL BAG

Approved
Approval ID

7b97c681-4514-c544-e053-2991aa0a3d78

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 29, 2024

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

6% HETASTARCH IN 0.9% SODIUM CHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1317
Application NumberBA740193
Product Classification
M
Marketing Category
C73584
G
Generic Name
6% HETASTARCH IN 0.9% SODIUM CHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 29, 2024
FDA Product Classification

INGREDIENTS (4)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
HETASTARCHActive
Quantity: 6 g in 100 mL
Code: 875Y4127EA
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 0.9 g in 100 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.